摘要:
The present invention provides a single-stage tunable Ultra-Wideband (UWB) pulse generator, by creating and differentiating a variable edge rate signal. Edge rate variability is introduced by first applying a step recovery diode (SRD) to compress the edges of the source and then applying a simple RC network to adjust the edge rate. Next, the resulting signal is differentiated using microstrip transmission lines. The tunable generator resulting from this approach demonstrates a Gaussian and monocycle pulses with good symmetry and low distortion over the tunable range.
摘要:
The present invention is a substrate dependent circuit modeling system for substrate-mounted components. The height and dielectric constant of a substrate have a significant impact on the frequency response of such components, and these effects cannot be treated independently from the circuit model. The equivalent circuit parameters in the model must be made to vary in accordance with changes in the substrate. The invention includes the steps of selecting a substrate mounted electrical circuit component for which an equivalent circuit model is desired, determining equivalent circuit model input parameters, wherein some of which are dependent upon characteristics of the substrate upon which the component is mounted, for the selected component, representing the selected electrical circuit component mounted upon the substrate as an equivalent electrical circuit, formulating mathematical expressions based upon the input parameters, and creating a unique equivalent circuit model for the component mounted upon the given substrate, the unique equivalent circuit model representing the mounting of the component upon the given substrate wherein the equivalent circuit model provides behavior and performance predictions of the component based upon the given substrate characteristics.
摘要:
The invention relates to novel benzo-fused heterocycles and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as endothelin receptor antagonists.
摘要:
The invention relates to novel acetamide derivatives of formula (I) and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of such compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as orexin receptor antagonists.
摘要:
The invention relates to novel 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as orexin receptor antagonists.
摘要:
The present invention is a substrate dependent circuit modeling system for substrate-mounted components. The height and dielectric constant of a substrate have a significant impact on the frequency response of such components, and these effects cannot be treated independently from the circuit model. The equivalent circuit parameters in the model must be made to vary in accordance with changes in the substrate. The invention includes the steps of selecting a substrate mounted electrical circuit component for which an equivalent circuit model is desired, determining equivalent circuit model input parameters, wherein some of which are dependent upon characteristics of the substrate upon which the component is mounted, for the selected component, representing the selected electrical circuit component mounted upon the substrate as an equivalent electrical circuit, formulating mathematical expressions based upon the input parameters, and creating a unique equivalent circuit model for the component mounted upon the given substrate, the unique equivalent circuit model representing the mounting of the component upon the given substrate wherein the equivalent circuit model provides behavior and performance predictions of the component based upon the given substrate characteristics.
摘要:
The present invention relates to aminocyclohexanol derivatives useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, tumors and/or hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes.
摘要:
The present invention relates to novel dihydroindole and tetrahydroquinoline derivatives and pharmaceutically acceptable salts and/or pharmaceutically acceptable esters thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, tumors and/or hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes.
摘要:
The present invention relates to compounds of formula (I) wherein U, Y, V, W, L, X, A1, A2, A3, A4, A5 and A6 are as defined in the description and claims and pharmaceutically acceptable salts and/or pharmaceutically acceptable esters thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasite infections, gallstones, tumors and/or hyperproliferative disorders, and/or treatment and/or prophylaxis of impaired glucose tolerance and diabetes.
摘要:
The present invention relates to indole derivatives, dihydroindole derivatives and pharmaceutically acceptable salts and/or pharmaceutically acceptable esters thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, tumors and/or hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes.